Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 6
2019 6
2020 9
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder.
Zheng W, Zhou YL, Liu WJ, Wang CY, Zhan YN, Li HQ, Chen LJ, Li MD, Ning YP. Zheng W, et al. J Affect Disord. 2019 Mar 1;246:241-247. doi: 10.1016/j.jad.2018.12.005. Epub 2018 Dec 10. J Affect Disord. 2019. PMID: 30590286 Clinical Trial.
Mediating effect of neurocognition between severity of symptoms and social-occupational function in anxious depression.
Liu W, Zhou Y, Zheng W, Wang C, Zhan Y, Li H, Chen L, Zhao C, Ning Y. Liu W, et al. Among authors: zhan y. J Affect Disord. 2019 Mar 1;246:667-673. doi: 10.1016/j.jad.2018.12.129. Epub 2018 Dec 26. J Affect Disord. 2019. PMID: 30611065
Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
Zhou Y, Zheng W, Liu W, Wang C, Zhan Y, Li H, Chen L, Ning Y. Zhou Y, et al. Among authors: zhan y. Psychoneuroendocrinology. 2019 Mar;101:72-79. doi: 10.1016/j.psyneuen.2018.11.001. Epub 2018 Nov 3. Psychoneuroendocrinology. 2019. PMID: 30419374
Repeated intravenous infusions of ketamine: Neurocognition in patients with anxious and nonanxious treatment-resistant depression.
Liu W, Zhou Y, Zheng W, Wang C, Zhan Y, Lan X, Zhang B, Li H, Chen L, Ning Y. Liu W, et al. Among authors: zhan y. J Affect Disord. 2019 Dec 1;259:1-6. doi: 10.1016/j.jad.2019.08.012. Epub 2019 Aug 12. J Affect Disord. 2019. PMID: 31430662
Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder.
Zheng W, Zhou YL, Liu WJ, Wang CY, Zhan YN, Li HQ, Chen LJ, Li MD, Ning YP. Zheng W, et al. J Psychopharmacol. 2019 Apr;33(4):494-501. doi: 10.1177/0269881119827811. Epub 2019 Feb 21. J Psychopharmacol. 2019. PMID: 30789302 Clinical Trial.
A preliminary study of anti-suicidal efficacy of repeated ketamine infusions in depression with suicidal ideation.
Zhan Y, Zhang B, Zhou Y, Zheng W, Liu W, Wang C, Li H, Chen L, Yu L, Walter M, Li M, Li MD, Ning Y. Zhan Y, et al. J Affect Disord. 2019 May 15;251:205-212. doi: 10.1016/j.jad.2019.03.071. Epub 2019 Mar 22. J Affect Disord. 2019. PMID: 30927581
Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression.
Zhou Y, Zheng W, Liu W, Wang C, Zhan Y, Li H, Chen L, Li M, Ning Y. Zhou Y, et al. Among authors: zhan y. Brain Behav Immun. 2018 Nov;74:205-212. doi: 10.1016/j.bbi.2018.09.007. Epub 2018 Sep 10. Brain Behav Immun. 2018. PMID: 30213652
Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression.
Zheng W, Zhou YL, Liu WJ, Wang CY, Zhan YN, Li HQ, Chen LJ, Li MD, Ning YP. Zheng W, et al. J Psychiatr Res. 2018 Nov;106:61-68. doi: 10.1016/j.jpsychires.2018.09.013. Epub 2018 Sep 25. J Psychiatr Res. 2018. PMID: 30278319
Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression.
Zhou Y, Zheng W, Liu W, Wang C, Zhan Y, Li H, Chen L, Li M, Ning Y. Zhou Y, et al. Among authors: zhan y. J Psychopharmacol. 2018 Oct;32(10):1118-1126. doi: 10.1177/0269881118798614. Epub 2018 Sep 27. J Psychopharmacol. 2018. PMID: 30260273 Clinical Trial.
A preliminary study of adjunctive ketamine for treatment-resistant bipolar depression.
Zheng W, Zhou YL, Liu WJ, Wang CY, Zhan YN, Lan XF, Zhang B, Ning YP. Zheng W, et al. J Affect Disord. 2020 Oct 1;275:38-43. doi: 10.1016/j.jad.2020.06.020. Epub 2020 Jun 25. J Affect Disord. 2020. PMID: 32658821
18 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback